Related Experiment Video
Updated: Jun 18, 2025
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
Visualizing cancer resistance via nano-quenching and recovery detector of CD44
Jialin Zeng1, Lihua Yang2, Lingke Zeng3
1Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.
Abstract:
Drug resistance to chemotherapy in cancers remains significant clinical challenges. CD44 modulates cellular adhesion, migration and growth, which plays a pivotal role in driving cancer resistance and even recurrence. Despite ongoing efforts, accurate, safe, and real-time dynamic monitoring techniques for CD44 expression remain inadequate in guiding the management of drug-resistant cancer treatment. In this study, we developed a nano-quenching and recovery detector of CD44 (Cy3-AptCD44@BPNSs) for visualizing cancer drug resistance. The fluorescence recovery of the detector is directly related to the CD44 expression level on cancer cells, which can be used to indicate the degree of drug resistance. It's confirmed that downregulating CD44 expression on cancer cells results in a corresponding decrease in the fluorescence intensity of the detector, which enables precise and dynamic monitoring of CD44. In addition, the Cy3-AptCD44@BPNSs also exhibited specificity in detecting CD44. This visualizing strategy may open up a wide range of possibilities for rapid recognition to cancer drug resistance, which is more efficient and flexible.
Insights
Researchers developed a novel detector (Cy3-AptCD44@BPNSs) to visualize cancer drug resistance by monitoring CD44 expression. This method allows for precise, real-time tracking of drug resistance, aiding treatment management.
Area of Science:
- Biomedical Engineering
- Molecular Oncology
- Nanotechnology
Background:
- Drug resistance in cancer chemotherapy presents a major clinical obstacle.
- CD44 protein is implicated in cancer cell adhesion, migration, growth, resistance, and recurrence.
- Current methods for monitoring CD44 expression in real-time are insufficient for guiding treatment decisions.
Purpose of the Study:
- To develop a novel detector for visualizing and dynamically monitoring CD44 expression in cancer cells.
- To establish a method for assessing cancer drug resistance based on CD44 levels.
- To provide a tool for more effective management of drug-resistant cancers.
Main Methods:
- Development of a nano-quenching and recovery detector (Cy3-AptCD44@BPNSs) targeting CD44.
- Utilizing fluorescence recovery of the detector to quantify CD44 expression levels.
- Validation of the detector's specificity and dynamic monitoring capabilities in cancer cells.
Main Results:
- The detector's fluorescence recovery directly correlates with CD44 expression levels.
- Downregulation of CD44 led to a measurable decrease in detector fluorescence intensity.
- The Cy3-AptCD44@BPNSs demonstrated high specificity for CD44 detection.
Conclusions:
- The developed detector enables precise and dynamic monitoring of CD44 expression.
- This visualizing strategy offers a promising approach for rapid recognition of cancer drug resistance.
- The method provides a more efficient and flexible tool for managing drug-resistant cancer treatment.
